Devyser Diagnostics Q3: High sales growth ahead of additional growth drivers - Redeye

Redeye embraces the strong sales growth in the quarter, and we emphasise the coming revenue growth drivers that should become more visible during 2024e. Coupled with a strong balance sheet (cash of SEK288m) and 50-60% discount to its peers’ EV/sales multiples, we argue the case remains undiscovered by the market, but that next year should likely begin triggering more interest.

Länk till analysen i sin helhet: https://www.redeye.se/research/957900/devyser-diagnostics-q3-high-sales-growth-ahead-of-additional-growth-drivers?utm_source=finwire&utm_medium=RSS